Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

NCT03934112 · tracked via the Priya Life Science France tracker

Sponsor

Centre Hospitalier Universitaire de Besancon

Phase

Observational

Started

2020-01-03

Last updated

2024-09-19

Condition(s) studied

Transfusion Related Complication

Study summary

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria.

These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies.

It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion criteria: * Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered * Patient admitted between 1st January 2012 to 31st December 2017

Primary outcome measure(s)

Survival at 90 days after leaving ICU — Day 90
All-cause mortality 90 days after leaving ICU

Trial sites (1)

Facility	City	Region	Status
CHU de Besançon	Besançon	France	Recruiting

More Centre Hospitalier Universitaire de Besancon trials in France

Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5 Starting soon

Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening Recruiting

Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old Recruiting

Influence of Sodium Intake in spondyLoarthriTes Recruiting

Orientation of the Lymphocyte Response to the Occurrence of Atherosclerotic Complications After Kidney Transplantation Active, not recruiting

Other trials for the same condition

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03934112 on ClinicalTrials.gov ↗ ← All trials in France